top
Search terms
Results 1 - 10 of 13 - ordered by :
Pages: 1 2
Ehjcvp

Vice versa, patients presenting with acute coronary syndromes (ACS) develop AF in 621% of cases, hence, through the presence of vascular disease, these patients automatically require anticoagulation ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Miklos Rohla, Thomas W. Weiss, Johann Wojta, Alexander Niessner, Kurt Huber

Date : 01/07/2015 Item size : 293945 bytes
Epeuropace

When a clinician has to decide on use of antithrombotic drugs in the setting of a patient affected by atrial fibrillation (AF) experiencing an acute coronary syndrome (ACS), the difficult task is ...

Europace, Editorial, Giuseppe Boriani, Deirdre A. Lane, Stephan Windecker, Kurt Huber, Paulus Kirchhof, Gregory Y.H. Lip

Date : 01/09/2015
Ehjournal

In the first of a two-part review, we discuss the choice of NOAC for stroke prevention in the following subgroups of patients with AF: (i) stable coronary artery disease or peripheral artery disease, ...

European Heart Journal, Diener, Hans-Christoph, Aisenberg, James, Ansell, Jack, Atar, Dan, Breithardt, Günter, Eikelboom, John, Ezekowitz, Michael D., Granger, Christopher B., Halperin, Jonathan ...

Date : 09/03/2017 Item size : 483367 bytes
Ehjournal

Strategies for managing these patients using the newer factor-specific oral anticoagulants are somewhat limited, as these patients represent a small fraction of the overall cohorts studied and only ...

European Heart Journal, Murphy, Sabina A., Giugliano, Robert P.

Date : 21/01/2014
Escardio

Luis Alberto GARCIA RODRIGUEZ (Madrid, ES) 08:30 P4860 Do changes in high on-treatment platelet reactivity predict cardiovascular events in patients undergoing percutaneous coronary intervention? A ...

Poster Session 6: Thrombosis and antithrombotic therapy

Date : 03/09/2013 Item size : 408495 bytes
Escardio

08:30 P1475 Determinants of post-discharge bleeding events in ACS patients during antiplatelet therapy: insight from the A-MATCH trial Young-Hoon JEONG (Jinju, Korea, Republic of) 08:30 P1476 Vitamin ...

Poster session 2: Platelets and antiplatelets therapy II

Date : 30/08/2015 Item size : 92668 bytes
Escardio

Insights from a single center PCI registry Roxana MEHRAN (New York, United States of America) 08:30 P1511 Association of a reduced antiplatelet activity of CYP3A4-metabolized statin with clinical ...

Poster session 2: Miscellaneous

Date : 30/08/2015 Item size : 107075 bytes
Ehjournal

In the first of a two-part review, we discuss the choice of NOAC for stroke prevention in the following subgroups of patients with AF: (i) stable coronary artery disease or peripheral artery disease, ...

European Heart Journal, Diener, Hans-Christoph, Aisenberg, James, Ansell, Jack, Atar, Dan, Breithardt, Günter, Eikelboom, John, Ezekowitz, Michael D., Granger, Christopher B., Halperin, Jonathan ...

Date : 21/03/2017 Item size : 490669 bytes
Ehjournal

Strategies for managing these patients using the newer factor-specific oral anticoagulants are somewhat limited, as these patients represent a small fraction of the overall cohorts studied and only ...

European Heart Journal, Murphy, Sabina A., Giugliano, Robert P.

Date : 21/01/2014
Ehjournal

In the first of a two-part review, we discuss the choice of NOAC for stroke prevention in the following subgroups of patients with AF: (i) stable coronary artery disease or peripheral artery disease, ...

European Heart Journal, Diener, Hans-Christoph, Aisenberg, James, Ansell, Jack, Atar, Dan, Breithardt, Günter, Eikelboom, John, Ezekowitz, Michael D., Granger, Christopher B., Halperin, Jonathan ...

Date : 21/03/2017 Item size : 522632 bytes